公司資料

Paragon 28 股價、新聞與催化劑

股票代碼:
FNA
交易所:
NYSE
產業:
MedTech
所在地:
United States

股價為何變動

Current closing-price context is not available for FNA.

公司概覽

業務概覽

Paragon 28 is a foot-and-ankle orthopedic device company focused on specialized surgical implants and instrumentation. The company’s strategy centers on procedure growth and surgeon adoption.

所在地與產業分類

Headquartered in the United States and listed on NYSE, Paragon 28 sits in procedure-driven medtech.

商業模式特徵

Its economics depend on surgical adoption, product launches, and the growth of the foot-and-ankle franchise.

生技產業定位

Paragon 28 is a niche orthopedic device company whose valuation is driven more by procedure execution than by biotech-style catalysts.

未來催化劑

  • Paragon 28's catalysts are foot-and-ankle implant adoption and continued surgeon penetration in a niche orthopedic market. The company needs more repeatable procedural share to keep re-rating.

近期新聞

    相似股票

    商業成熟度、治療領域或催化劑模式相近的同業公司。